A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
about
Vaccines for preventing Japanese encephalitisTackling dengue fever: Current status and challengesProduct review on the JE vaccine IXIAROJapanese encephalitis: the virus and vaccinesStable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit VaccineVero cell platform in vaccine production: moving towards cell culture-based viral vaccines.An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.New Japanese encephalitis vaccines: alternatives to production in mouse brain.Japanese encephalitis vaccine for travelers: exploring the limits of risk.Japanese encephalitis vaccines: moving away from the mouse brain.Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.Recent advancement in flavivirus vaccine development.A chimeric live attenuated vaccine against Japanese encephalitis.Development of a new hydrogen peroxide–based vaccine platform.Japanese encephalitis: development of new candidate vaccines.Current use and development of vaccines for Japanese encephalitis.IC51 Japanese encephalitis vaccine.Ixiaro: a new vaccine against Japanese encephalitis.IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.IXIARO(®) updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.Japanese Encephalitis: A Persistent Threat
P2860
Q24243819-963689F4-FC70-42A3-8CEF-C8A2A52391DFQ24288867-00402D5A-1737-4402-8EA1-515717C23F6AQ26866171-BFB353D4-2F8D-4703-85AB-99BB0E43BAE3Q27010434-A9431E20-AF27-4B0A-B791-C6B679C948B0Q27477712-09A1F748-A729-487E-944B-D7C4FAB8BA72Q30376550-46E0A528-A9CF-48CF-8287-1961E950AB53Q33923199-E6558E2C-4BFF-483D-9515-23CED000071BQ34173039-D194B7DF-13C6-4C4F-A1A8-6033F26A4849Q34711618-B8AC27F2-DAB6-4D88-9324-458115C09DD6Q35194191-DBA63E86-9D95-4478-B6CF-29C17D9438E0Q35666240-80D71681-C047-4A49-A832-CFA7118EC65FQ35728621-E1B04BBA-C5B8-4B8C-B643-B17B73BB62F9Q35791746-FFC86066-6FE5-47DE-9DEC-8E29002DEF08Q36423118-010EB8F4-3C22-4C0C-B111-7677D9C6F65DQ36441519-524D2613-9CCD-4E8C-905A-0D893D62EA6DQ37032646-E08D36F0-00E4-46C5-A2B4-8B13B96D4914Q37519659-F3635494-188A-407B-8850-27463E8F52A1Q37622889-8FF2FE86-FA4F-4DAF-959C-74DDD050E7A5Q38132263-04797AC2-80E4-42F4-95A2-C2268D33C686Q38389189-0035DB94-5DBC-4A03-9CB8-84FA84FD4272Q38544959-5AAA6A4D-64CE-4AB5-9D4B-09018897601EQ39103445-CECF94A1-3EF0-4CA1-8FA3-3E46A0CBD004Q40423085-5F797AEC-613F-41FB-983B-469F979FD17DQ56749528-C69EAC30-E137-42EC-A60F-2ED9D04E6ABB
P2860
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
@en
type
label
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
@en
prefLabel
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
@en
P2093
P1433
P1476
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells
@en
P2093
A K Srivastava
D A Barvir
D W Vaughn
J R Putnak
K H Eckels
P304
P356
10.1016/S0264-410X(01)00208-0
P407
P577
2001-08-01T00:00:00Z